Silk Road Medical, Inc (SILK)
NASDAQ: SILK · IEX Real-Time Price · USD
+0.01 (0.04%)
At close: Jul 11, 2024, 4:00 PM
-0.06 (-0.22%)
After-hours: Jul 11, 2024, 6:56 PM EDT

Silk Road Medical Revenue

Silk Road Medical had revenue of $185.49M in the twelve months ending March 31, 2024, with 23.04% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $48.48M with 20.81% year-over-year growth. In the year 2023, Silk Road Medical had annual revenue of $177.13M with 27.77% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.07B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023177.13M38.50M27.77%
Dec 31, 2022138.64M37.16M36.62%
Dec 31, 2021101.48M26.25M34.89%
Dec 31, 202075.23M11.87M18.74%
Dec 31, 201963.35M28.80M83.33%
Dec 31, 201834.56M20.30M142.37%
Dec 31, 201714.26M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AtriCure 414.60M
Artivion 368.21M
Xencor 162.18M
Calliditas Therapeutics AB (publ) 119.73M
Prothena Corporation 89.25M
Vir Biotechnology 79.60M
Tarsus Pharmaceuticals 42.56M
4D Molecular Therapeutics 20.45M
Revenue Rankings